GALE 📈 Galenica Sante - Overview

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0360674466

GALE: Pharmaceuticals, Parapharmaceuticals, Consumer Health Products, Medication

Galenica Sante AG is a leading healthcare service provider with a strong presence in Switzerland and international markets. The company operates through two distinct business segments: Products & Care, and Logistics & IT.

The Products & Care segment is a retail powerhouse, operating a network of pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also specializes in providing medication for patients in the comfort of their own homes. Furthermore, it develops and distributes a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, while offering marketing and sales services to partners in the healthcare market.

In addition to its retail presence, Galenica Sante AG's Products & Care segment is also a key player in the healthcare market, providing a range of value-added services to its partners. This includes support for product launches, distribution, and marketing, making it a one-stop-shop for healthcare companies looking to expand their reach in Switzerland and beyond.

The Logistics & IT segment is a specialized service provider, offering a range of pre-wholesale services to pharmaceutical and healthcare companies. These services include storage, distribution, and debt collection, ensuring that healthcare products reach their destination efficiently and effectively. This segment also develops and maintains a master data system for the healthcare market, providing a centralized platform for healthcare companies to manage their data.

In addition to its logistics expertise, Galenica Sante AG's Logistics & IT segment also offers a range of management solutions for the healthcare market, including group internal IT services and technical information on pharmaceutical products. This makes it a trusted partner for healthcare companies looking to streamline their operations and improve their bottom line.

With a rich history dating back to 1927, Galenica Sante AG is headquartered in Bern, Switzerland, and has established itself as a trusted and reliable partner in the healthcare industry. For more information, visit their website at https://www.galenica.com.

Additional Sources for GALE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GALE Stock Overview

Market Cap in USD 4,309m
Sector Healthcare
Industry Medical Distribution
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception

GALE Stock Ratings

Growth 5y 48.6%
Fundamental 67.9%
Dividend 37.7%
Rel. Performance Sector -0.41
Analysts -
Fair Price Momentum 75.42 CHF
Fair Price DCF 89.59 CHF

GALE Dividends

Dividend Yield 12m 1.44%
Yield on Cost 5y 1.94%
Annual Growth 5y -8.34%
Payout Consistency 93.16%

GALE Growth Ratios

Growth Correlation 3m 75.8%
Growth Correlation 12m 45.8%
Growth Correlation 5y 83.2%
CAGR 5y 6.20%
CAGR/Mean DD 5y 0.75
Sharpe Ratio 12m 0.34
Alpha -2.63
Beta 0.22
Volatility 13.77%
Current Volume 77.6k
Average Volume 20d 72.4k
What is the price of GALE stocks?
As of December 05, 2024, the stock is trading at CHF 76.60 with a total of 77,627 shares traded.
Over the past week, the price has changed by +2.12%, over one month by -0.32%, over three months by +6.27% and over the past year by +8.50%.
Is Galenica Sante a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Galenica Sante (SW:GALE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.94 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GALE as of December 2024 is 75.42. This means that GALE is currently overvalued and has a potential downside of -1.54%.
Is GALE a buy, sell or hold?
Galenica Sante has no consensus analysts rating.
What are the forecast for GALE stock price target?
According to ValueRays Forecast Model, GALE Galenica Sante will be worth about 81.5 in December 2025. The stock is currently trading at 76.60. This means that the stock has a potential upside of +6.33%.
Issuer Forecast Upside
Wallstreet Target Price 76.9 0.4%
Analysts Target Price - -
ValueRay Target Price 81.5 6.3%